Clinical Trials Directory

Trials / Completed

CompletedNCT05149651

Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

Clinical and Radiographic Outcomes of Pulpotomy of Primary Molars Using Totalfill® Bioceramic Root Repair Material -Fast Set Putty, and ProRoot White MTA®. A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
University Ghent · Academic / Other
Sex
All
Age
3 Years – 9 Years
Healthy volunteers
Accepted

Summary

An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.

Detailed description

When a tooth decay is too deep and extended into the tooth pulp, then the tooth is not indicated to be treated with a filling. Therefore, removing the diseased pulp and then cover the rest with a suitable material is required. The Purpose of this study is to check the success of pulp treatment on deciduous molars with deep caries using 2 pulp treatment agents: (Totalfill® and MTA®). The use between the materials is randomly assigned. However, the use of the materials has no side effect or complications as it is a routine dental procedure. The participants are healthy children aged between 3 and 9 years old, and the study is taking place in Ghent University Hospital, Ghent, Belgium, and it is planned to be conducted in duration of 4 years, which include 20 months for participants recruitment. After placing the material, the tooth is restored with stainless steel crowns, and the participant was asked for follow up to check the tooth and to take dental x-ray every 6 months.

Conditions

Interventions

TypeNameDescription
DRUGTotalfillTotalfill® Bioceramic Root Repair Material -Fast Set Putty is a pre-mixed, bioactive calcium silicate cement which used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy.
DRUGMTAProRoot White MTA® is a bioactive calcium silicate cement which used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy.

Timeline

Start date
2017-01-01
Primary completion
2018-12-31
Completion
2020-12-31
First posted
2021-12-08
Last updated
2023-11-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05149651. Inclusion in this directory is not an endorsement.